Register for the ISN Webinar on Thrombotic MicroangiopathiesReema Parmar
The ISN and the Mario Negri Institute for Pharmacological Research will hold the first of two webinars on September 17, 2021, at 2 p.m. CEST on:
“New Insights into Clinical Management of Complement-mediated Thrombotic Microangiopathies”
The webinar will address:
- Identifying patients with complement-mediated TMA
- The impact of genetic and biochemical characterization
- Treatment recommendations
- Clinical perspectives of emerging complement inhibitors
The webinar supports the ISN Frontiers Meeting “Complement-related Kidney Diseases: Classification, Genetics, and Treatment,” which will take place in Bergamo from June 23-25, 2022.
The ISN Frontiers meetings offer cutting-edge science and state-of-the-art lectures in specialist topics to a global audience. The Bergamo edition will focus on the two prototypical complement-mediated kidney diseases: atypical hemolytic uremic syndrome (aHUS) and C3 Glomerulopathies /Membranoproliferative Glomerulonephritis (C3G/MPGN), both very rare and severe conditions.